The Recimagine™ Ecosystem
Integrating Digital Intelligence, PAT, and Continuous Processing to Accelerate Innovation
Developing and manufacturing advanced therapeutics remains costly, slow, and often struggles with efficient product characterization and quality control. To address these challenges, the Recimagine™ ecosystem rethinks every stage of production, integrating in silico process development and optimization, inline process analytical technologies (PAT), and continuous processing to accelerate development and manufacturing, reduce costs, and elevate quality. Recimagine solutions are enabling smarter, faster, and more equitable access to next-generation medicines.
Challenges Slowing the Growth of Advanced Therapeutics
Despite the promise of mRNA and other advanced modalities, the industry continues to face significant barriers that limit scalability, accessibility, and speed to market.
Building and operating GMP-compliant facilities for mRNA production often requires $100–200 million in capital investment, which is prohibitively expensive for many innovators. Meanwhile, the cost of goods for mRNA vaccines and therapeutics remains two to four times higher than for traditional vaccines and other therapeutic modalities, hindering accessibility and affordability.
Conventional trial-and-error approaches to process development create uncertainty and extended timelines. Optimizing IVT yield, LNP formulation, and scale-up under GMP conditions can take one and a half to three years, delaying delivery of life-saving therapies.
Many advanced therapies remain poorly characterized, leading to variability and risk. dsRNA impurities can trigger unwanted immune responses, while inconsistency in mRNA purity, capping efficiency, and LNP size introduces significant quality challenges and batch-to-batch variability.
A Transformative Ecosystem for Next-Generation Biomanufacturing
The three pillars of the Recimagine ecosystem platforms redefine therapeutic manufacturing by connecting digital process design, real-time analytics, and continuous production. Together, these solutions create an intelligent, end-to-end solution for next-generation biologics and xRNA medicines.
Recimagine™ Continuous Production System
Intelligent, end-to-end continuous manufacturing of xRNA therapeutics and vaccines, coupled with PAT-driven real-time release, allows for the continuous flow of material from upstream reactions to fill finish, ultimately decreasing production time from months to days.
Learn More
Recimagine™ Continuous Production System
Intelligent, end-to-end continuous manufacturing of xRNA therapeutics and vaccines, coupled with PAT-driven real-time release, allows for the continuous flow of material from upstream reactions to fill finish, ultimately decreasing production time from months to days.
Learn More
Recimagine™ Simulator
A virtual process development allows teams to design, test, and refine manufacturing strategies entirely in silico before committing resources to the lab.
Learn More
Recimagine™ Simulator
A virtual process development allows teams to design, test, and refine manufacturing strategies entirely in silico before committing resources to the lab.
Learn More
Recimagine™ PAT
Universal, modular, multi-attribute analytics skid that acts as “QC on wheels.” Recimagine PAT is more than a testing tool; it provides the digital backbone for intelligent manufacturing.
Learn More
Recimagine™ PAT
Universal, modular, multi-attribute analytics skid that acts as “QC on wheels.” Recimagine PAT is more than a testing tool; it provides the digital backbone for intelligent manufacturing.
Learn More
Each Node of the Recimagine™ Ecosystem Supports and Learns from the Others
Recimagine is an interconnected ecosystem, where insights flow seamlessly, creating a self-reinforcing integrated framework where insights flow seamlessly between digital design, real-time analytics, and continuous production to drive smarter, more efficient biomanufacturing.
Knowledge Hub
- Orchestration
- Digital Twins
- Data Lake
Process Development Suite
- Recimagine Simulator
- High Throughout Screening
- Scale Down Modeling
Continuous Manufacturing
- Real Time Release
- Continuous Product Flow
- Inline QC Insight
PAT
- Multi-Attribute Hardware
- Advanced Modeling Software
- Predictive Control
- Multi-Attribute Hardware
- Advanced Modeling Software
- Predictive Control
Transform Development and Manufacturing with Recimagine™
The Recimagine ecosystem tackles the toughest challenges in therapeutic production, including high costs, inefficient development, and inconsistent quality. Together, we can reimagine how life-changing therapies are made and deliver them to patients faster than ever before. Partner with us to accelerate what’s next.